258 related articles for article (PubMed ID: 34755530)
1. Combined control of the fibroblast contractile program by YAP and TAZ.
Link PA; Choi KM; Diaz Espinosa AM; Jones DL; Gao AY; Haak AJ; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2022 Jan; 322(1):L23-L32. PubMed ID: 34755530
[TBL] [Abstract][Full Text] [Related]
2. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
[TBL] [Abstract][Full Text] [Related]
3. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
[TBL] [Abstract][Full Text] [Related]
5. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
[TBL] [Abstract][Full Text] [Related]
6. M2 macrophages promote subconjunctival fibrosis through YAP/TAZ signalling.
Wang Y; Geng X; Guo Z; Chu D; Liu R; Cheng B; Cui H; Li C; Li J; Li Z
Ann Med; 2024 Dec; 56(1):2313680. PubMed ID: 38335557
[TBL] [Abstract][Full Text] [Related]
7. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
[TBL] [Abstract][Full Text] [Related]
8. The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.
Zmajkovicova K; Menyhart K; Bauer Y; Studer R; Renault B; Schnoebelen M; Bolinger M; Nayler O; Gatfield J
Am J Respir Cell Mol Biol; 2019 May; 60(5):578-591. PubMed ID: 30537446
[TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response.
Caire R; Audoux E; Courbon G; Michaud E; Petit C; Dalix E; Chafchafi M; Thomas M; Vanden-Bossche A; Navarro L; Linossier MT; Peyroche S; Guignandon A; Vico L; Paul S; Marotte H
Front Immunol; 2021; 12():791907. PubMed ID: 34956224
[TBL] [Abstract][Full Text] [Related]
12. Roles and mechanisms of YAP/TAZ in orthodontic tooth movement.
Deng L; Chen Y; Guo J; Han X; Guo Y
J Cell Physiol; 2021 Nov; 236(11):7792-7800. PubMed ID: 33843049
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity.
Murakami Y; Imaizumi T; Hashizume K; Tezuka Y; Oku Y; Nishiya N; Sanbe A; Kurosaka D
J Ocul Pharmacol Ther; 2024 May; 40(4):246-252. PubMed ID: 38517736
[No Abstract] [Full Text] [Related]
14. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
15. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
[TBL] [Abstract][Full Text] [Related]
16. YAP/TAZ Signaling Enhances Angiogenesis of Retinal Microvascular Endothelial Cells in a High-Glucose Environment.
Wang XL; Xian Y; Chen XL
Curr Eye Res; 2024 May; 49(5):524-532. PubMed ID: 38305219
[TBL] [Abstract][Full Text] [Related]
17. Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis.
Gui Y; Li J; Lu Q; Feng Y; Wang M; He W; Yang J; Dai C
J Biol Chem; 2018 Oct; 293(42):16364-16375. PubMed ID: 30154246
[TBL] [Abstract][Full Text] [Related]
18. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
Lui JW; Moore SPG; Huang L; Ogomori K; Li Y; Lang D
Pigment Cell Melanoma Res; 2022 Jan; 35(1):52-65. PubMed ID: 34468072
[TBL] [Abstract][Full Text] [Related]
19. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibition of YAP/TAZ alters the biological behaviours of keloid fibroblasts.
Gao N; Lu L; Ma X; Liu Z; Yang S; Han G
Exp Dermatol; 2022 Mar; 31(3):320-329. PubMed ID: 34623712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]